1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [4c5eeb3a-0e12-454f-b731-a57021a22f3a] => Array ( [runtime-id] => 4c5eeb3a-0e12-454f-b731-a57021a22f3a [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [c70a8d3d-0a65-4a07-88b9-d33ea92dff6a] => Array ( [runtime-id] => c70a8d3d-0a65-4a07-88b9-d33ea92dff6a [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;604fac0265f7344bf33eb35dca1b451d76bcc2a0 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [4c5eeb3a-0e12-454f-b731-a57021a22f3a] => Array ( [runtime-id] => 4c5eeb3a-0e12-454f-b731-a57021a22f3a [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [c70a8d3d-0a65-4a07-88b9-d33ea92dff6a] => Array ( [runtime-id] => c70a8d3d-0a65-4a07-88b9-d33ea92dff6a [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;604fac0265f7344bf33eb35dca1b451d76bcc2a0 ) ) )Table 2:The clinical characteristics of pediatric patients with rare TSCa
Characteristics Controlled (n = 97) Uncontrolled (n = 203) P Value Male (No.) (%) 56 (57.7%) 107 (52.7%) .416 Age at onset (mean) (months) 30.44 (SD, 33.17) 17.35 (SD, 26.22) <.001b Age at imaging (mean) (months) 57.01 (SD, 45.18) 36.27 (SD, 40.37) <.001b Infantile spasms (No.) (%) 21 (21.6%) 93 (45.8%) <.001b Epilepsy (No.) (%) 97 (100.0%) 203 (100.0%) ASM numbers (≥3), n (%) 42 (43.3%) 171 (84.2%) <.001b Focal epilepsy (No.) (%) 75 (77.3%) 16 5 (81.3%) .424